Compounds > pravastatin
Page last updated: 2024-08-23

pravastatin and Leishmaniasis, Cutaneous

pravastatin has been researched along with Leishmaniasis, Cutaneous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kückelhaus, CS; Kückelhaus, SA; Muniz-Junqueira, MI; Tosta, CE1
Kückelhaus, CS; Kückelhaus, SA; Muniz-Junqueira, MI1

Other Studies

2 other study(ies) available for pravastatin and Leishmaniasis, Cutaneous

ArticleYear
Pravastatin modulates macrophage functions of Leishmania (L.) amazonensis-infected BALB/c mice.
    Experimental parasitology, 2013, Volume: 134, Issue:1

    Topics: Animals; Female; Hydrogen Peroxide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages; Mice; Mice, Inbred BALB C; Nitric Oxide; Phagocytosis; Pravastatin; Tumor Necrosis Factor-alpha

2013
Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis.
    Experimental parasitology, 2011, Volume: 127, Issue:3

    Topics: Analysis of Variance; Animals; Antiprotozoal Agents; Body Weight; Cricetinae; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pravastatin; Statistics, Nonparametric; Survival Rate

2011